China Cord Blood Corp. (NYSE:CO) hit a new 52-week low on Wednesday . The stock traded as low as $5.25 and last traded at $5.25, with a volume of 23,600 shares trading hands. The stock had previously closed at $5.30.

Several equities research analysts have recently weighed in on CO shares. Zacks Investment Research cut China Cord Blood Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday, July 12th. TheStreet cut China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $8.33.

The firm has a market capitalization of $419.63 million and a price-to-earnings ratio of 27.87. The company has a 50 day moving average of $5.53 and a 200-day moving average of $5.91.

China Cord Blood Corp. (NYSE:CO) last posted its earnings results on Tuesday, June 14th. The company reported $0.03 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.03. The business had revenue of $24.30 million for the quarter. Equities analysts forecast that China Cord Blood Corp. will post $0.17 EPS for the current fiscal year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.